Founded in 2003, Biodel is a pharmaceutical company that develops novel formulations for therapeutic care solutions. It offers medicines for the treatment of various endocrine disorders, including diabetes and osteoporosis. The company uses VIAdel technology, which enables delivery of endocrine therapeutics into blood through various routes of administration. Biodel also offers VIAject, which is an injectable human insulin product. It provides VIAtab, which is an oral human insulin product. The company offers VIAmass and VIAcal that formulates parathyroid hormone and salmon calcitonin for the treatment of osteoporosis. Additionally, Biodel provides a variety of clinical trial services and organizes various community events.